Biothera
Biothera Pharmaceuticals, Inc. is advancing Imprime PGG, a unique cancer immunotherapy, through Phase 2 clinical trials in multiple cancer indications in combination with checkpoint inhibitor therapy. including response, safety and biomarker data, are expected through 2017-18.